1. Overexpression of miR-100 inhibits cancer growth, migration, and chemosensitivity in human NSCLC cells through fibroblast growth factor receptor 3
   Jie Luo et al, 2016, Tumor Biology CrossRef
2. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features
   M. Zuberi et al, 2015, Clinical and Translational Oncology CrossRef
3. miR-200c Regulation of Metastases in Ovarian Cancer: Potential Role in Epithelial and Mesenchymal Transition
   Siti A. Sulaiman et al, 2016, Frontiers in Pharmacology CrossRef
4. MicroRNAs in Respiratory Diseases
   Gema Mondejar-Parreño et al, 2019, Nucleic Acid Nanotheranostics CrossRef
5. MiRNA-200C expression in Fanconi anemia pathway functionally deficient lung cancers
   Wenrui Duan et al, 2021, Scientific Reports CrossRef
6. Gene regulation and prognostic indicators of lung squamous cell carcinoma: TCGA‐derived miRNA/mRNA sequencing and DNA methylation data
   Yuzhou Shen et al, 2019, Journal of Cellular Physiology CrossRef
7. MiRNA-200a expression is inverse correlation with hepatocyte growth factor expression in stromal fibroblasts and its high expression predicts a good prognosis in patients with non-small cell lung cancer
   Yongbing Chen et al, 2016, Oncotarget CrossRef
8. Beyond circulating microRNA biomarkers: Urinary microRNAs in ovarian and breast cancer
   Maria Luisa Gasparri et al, 2017, Tumor Biology CrossRef
9. Direct targeting of MAPK8IP1 by miR-10a-5p is a major mechanism for gastric cancer metastasis
   Yaoyong Lu et al, 2017, Oncology Letters CrossRef
10. Deleted in Liver Cancer-1 (DLC1): An Emerging Metastasis Suppressor Gene
    Nicholas C. Popescu et al, 2014, Molecular Diagnosis & Therapy CrossRef
11. The Role of miRNAs in Bone Metastasis and their Significance in the Detection of Bone Metastasis: A Review of the Published Data
    Qian Huang et al, 2015, Future Oncology CrossRef
12. miR-200b as a prognostic factor targets multiple members of RAB family in glioma
    Qing Liu et al, 2014, Medical Oncology CrossRef
13. MicroRNA Regulation of the Small Rho GTPase Regulators—Complexities and Opportunities in Targeting Cancer Metastasis
    Brock A. Humphries et al, 2020, Cancers CrossRef
14. New insights into lung development and diseases: the role of microRNAs
    Dina Johar et al, 2015, Biochemistry and Cell Biology CrossRef
15. microRNA-664 enhances proliferation, migration and invasion of lung cancer cells
    Xinhai Zhu et al, 2017, Experimental and Therapeutic Medicine CrossRef
16. miR-200b/c attenuates lipopolysaccharide-induced early pulmonary fibrosis by targeting ZEB1/2 via p38 MAPK and TGF-β/smad3 signaling pathways
    Yongmei Cao et al, 2018, Laboratory Investigation CrossRef
17. The microRNA-183/96/182 cluster inhibits lung cancer progression and metastasis by inducing an interleukin-2-mediated antitumor CD8+ cytotoxic T-cell response
    Samrat T. Kundu et al, 2022, Genes & Development CrossRef
18. Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway
    HAI JIN et al, 2015, Oncology Reports CrossRef
19. Decreased Expression of the Chromatin Remodeler ATRX Associates with Melanoma Progression
    Zulekha A. Qadeer et al, 2014, Journal of Investigative Dermatology CrossRef
20. DNMT1/miR-200a/GOLM1 signaling pathway regulates lung adenocarcinoma cells proliferation
    Longqiu Yang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
21. MiRNA-141 and miRNA-200b are closely related to invasive ability and considered as decision-making biomarkers for the extent of PLND during cystectomy
    Wentao Liu et al, 2015, BMC Cancer CrossRef
22. MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non small cell lung cancer
    Feiye Liu et al, 2017, Molecular Cancer CrossRef
23. Members of the microRNA-200 family are promising therapeutic targets in cancer
    Ying Chen et al, 2017, Experimental and Therapeutic Medicine CrossRef
24. Diallyl disulfide suppresses proliferation and induces apoptosis in human gastric cancer through Wnt-1 signaling pathway by up-regulation of miR-200b and miR-22
    Hailin Tang et al, 2013, Cancer Letters CrossRef
25. MicroRNA-106b promotes colorectal cancer cell migration and invasion by directly targeting DLC1
    Guang-jun Zhang et al, 2015, Journal of Experimental & Clinical Cancer Research CrossRef
26. Pathology of Brain Metastasis
    Dana A. Mustafa et al, 2020, Central Nervous System Metastases CrossRef
27. Molecular mechanisms of microRNAs in regulating epithelial–mesenchymal transitions in human cancers
    Jinlong Tang et al, 2016, Cancer Letters CrossRef
28. Chemical modification patterns for microRNA therapeutic mimics: a structure-activity relationship (SAR) case-study on miR-200c
    Marion Garreau et al, 2024, Nucleic Acids Research CrossRef
29. Over-expression of cofilin-1 suppressed growth and invasion of cancer cells is associated with up-regulation of let-7 microRNA
    Cheng-Han Tsai et al, 2015, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
30. Colorectal cancer-derived exosomal miR-106b-3p promotes metastasis by down-regulating DLC-1 expression
    He Liu et al, 2020, Clinical Science CrossRef
31. Decreased expression of microRNA-200b is an independent unfavorable prognostic factor for glioma patients
    Donghai Men et al, 2014, Cancer Epidemiology CrossRef
32. miRNA-200c inhibits invasion and metastasis of human non-small cell lung cancer by directly targeting ubiquitin specific peptidase 25
    Jing Li et al, 2014, Molecular Cancer CrossRef
33. MicroRNA‐200 families and prognostic value in various carcinomas: A systematic review and meta‐analysis
    Yuan Yin et al, 2018, AGING MEDICINE CrossRef
34. Recent advances of microRNA-based molecular diagnostics to reduce false-positive lung cancer imaging
    Mattia Boeri et al, 2015, Expert Review of Molecular Diagnostics CrossRef
35. MicroRNA Signature Characterizes Primary Tumors That Metastasize in an Esophageal Adenocarcinoma Rat Model
    Ali H. Zaidi et al, 2015, PLOS ONE CrossRef
36. Genetic variants in regulatory regions of microRNAs are associated with lung cancer risk
    Kaipeng Xie et al, 2016, Oncotarget CrossRef
37. Comprehensive Analysis of Correlations in the Expression of miRNA Genes and Immune Checkpoint Genes in Bladder Cancer Cells
    Przemysław A. Stempor et al, 2021, International Journal of Molecular Sciences CrossRef
38. The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers
    S T Kundu et al, 2016, Oncogene CrossRef
39. Characterization of the MicroRNA Expression Profile of Cervical Squamous Cell Carcinoma Metastases
    Hui Ding et al, 2014, Asian Pacific Journal of Cancer Prevention CrossRef
40. High HNRNPA3 expression is associated with lymph node metastasis and poor prognosis in patients treated with radical cystectomy
    Noriyuki Amano et al, 2021, Urologic Oncology: Seminars and Original Investigations CrossRef
41. Genome-wide identification and expression analysis of microRNA involved in small cell lung cancer via deep sequencing
    CHUNHUA YAN et al, 2014, Molecular Medicine Reports CrossRef
42. Novel alternative tools for metastatic pheochromocytomas/paragangliomas prediction
    Y. Cui et al, 2024, Journal of Endocrinological Investigation CrossRef
43. miR-200b suppresses cell proliferation, migration and enhances chemosensitivity in prostate cancer by regulating Bmi-1
    JUNJIE YU et al, 2014, Oncology Reports CrossRef
44. MiR-200, a new star miRNA in human cancer
    Xiangling Feng et al, 2014, Cancer Letters CrossRef
45. LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis
    Shuquan Wei et al, 2019, International Journal of Immunopathology and Pharmacology CrossRef
46. The emerging role of microRNAs in resistance to lung cancer treatments
    Lauren MacDonagh et al, 2015, Cancer Treatment Reviews CrossRef
47. MicroRNA-200c and microRNA-31 regulate proliferation, colony formation, migration and invasion in serous ovarian cancer
    Fateen Farhana Ibrahim et al, 2015, Journal of Ovarian Research CrossRef
48. Thrombospondin‐1 and microRNA‐1 expression in response to multiwalled carbon nanotubes in alveolar epithelial cells
    M. Pacurari et al, 2017, Environmental Toxicology CrossRef
49. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma
    Yifan Li et al, 2019, eBioMedicine CrossRef
50. miR-200b inhibits migration and invasion in non-small cell lung cancer cells via targeting FSCN1
    Peng Xiao et al, 2016, Molecular Medicine Reports CrossRef
51. miR‑200b upregulation promotes migration of BEAS‑2B cells following long‑term exposure to cigarette smoke by targeting ETS1
    Jin Wang et al, 2021, Molecular Medicine Reports CrossRef
52. Metadherin regulates proliferation and metastasis via actin cytoskeletal remodelling in non-small cell lung cancer
    Y Yao et al, 2014, British Journal of Cancer CrossRef
53. miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance
    Merve Mutlu et al, 2016, Journal of Molecular Medicine CrossRef
54. The miRacle in Pancreatic Cancer by miRNAs: Tiny Angels or Devils in Disease Progression
    Zuhair Hawa et al, 2016, International Journal of Molecular Sciences CrossRef
55. Overexpression of secretagogin inhibits cell apoptosis and induces chemoresistance in small cell lung cancer under the regulation of miR-494
    Yifeng Bai et al, 2014, Oncotarget CrossRef
56. Role of epigenetics in lung cancer heterogeneity and clinical implication
    Nian Dong et al, 2017, Seminars in Cell & Developmental Biology CrossRef
57. MiR-200a negatively regulates TGF-β1-induced epithelial-mesenchymal transition of peritoneal mesothelial cells by targeting ZEB1/2 expression
    Runsheng Guo et al, 2018, American Journal of Physiology-Renal Physiology CrossRef
58. miR-141 and miR-200c as Markers of Overall Survival in Early Stage Non-Small Cell Lung Cancer Adenocarcinoma
    Rut Tejero et al, 2014, PLoS ONE CrossRef
59. MicroRNA-200b and -301 are associated with gemcitabine response as biomarkers in pancreatic carcinoma cells
    Naotake Funamizu et al, 2019, International Journal of Oncology CrossRef
60. The Regulatory Role of MicroRNAs in EMT and Cancer
    Apostolos Zaravinos, 2015, Journal of Oncology CrossRef
61. Diagnostic value of microRNA-200 expression in peripheral blood-derived extracellular vesicles in early-stage non-small cell lung cancer
    Lina Liu et al, 2024, Clinical and Experimental Medicine CrossRef
62. Therapeutic Use of MicroRNAs in Lung Cancer
    Orazio Fortunato et al, 2014, BioMed Research International CrossRef
63. miR-200b as a prognostic factor in breast cancer targets multiple members of RAB family
    Feng Ye et al, 2014, Journal of Translational Medicine CrossRef
64. Heterogeneous nuclear ribonucleoprotein A/B: an emerging group of cancer biomarkers and therapeutic targets
    Ya Lu et al, 2022, Cell Death Discovery CrossRef
65. Interleukin-23 promotes the epithelial-mesenchymal transition of oesophageal carcinoma cells via the Wnt/β-catenin pathway
    Deyu Chen et al, 2015, Scientific Reports CrossRef
66. Non-coding RNAs as emerging regulators of epithelial to mesenchymal transition in non-small cell lung cancer
    Ying Chen et al, 2017, Oncotarget CrossRef